HUMAN PHYSIOLOGICAL AREAS

Ophthalmic area

Retina, pigment epithelium and ocular surface: the in vitro models used to check whether an ingredient or a supplement really acts on eye health.

OPHTHALMIC

What you can demonstrate here

Lutein, zeaxanthin, anthocyanins: the category is crowded and products look alike. What sets them apart is the mechanism measured on the tissue where the ingredient has to act, the retina or the surface of the eye. In vitro data do not substantiate a health claim on their own: they substantiate the choice of form and dose, the comparison with the category reference and the technical dossier for downstream customers.

The models we use

Retinal pigment epitheliumRetinal cellsBlood-retinal barrier modelOcular surface epitheliumChemical-analytical methods

What we measure

Retinal cytoprotection
  • Viability and oxidative stress after oxidative insult
  • Protection from blue-light stress
Retinal inflammation
  • Anti-inflammatory activity on retinal pigment epithelium and retinal cells
Blood-retinal barrier
  • VEGF release under high glucose
  • Barrier integrity
Ocular surface
  • In vitro models of the ocular surface epithelium
Bioavailability
  • Simulated gastrointestinal digestion before the test, so the model receives what actually arrives after intake

What is measured in this area

Retina, barrier and ocular surface: the endpoints used to check whether an ingredient affects the mechanisms behind eye health.

  • Retinal cell viability — after oxidative and blue-light insult
  • Oxidative stress — in the retinal pigment epithelium
  • Inflammatory response — markers of retinal inflammation
  • VEGF release — under high glucose
  • Blood-retinal barrier — integrity of the barrier model
  • Ocular surface — models of the surface epithelium
  • Simulated digestion — the ingredient as it is after transit
  • Comparison with the reference — same conditions, same model

What you receive

  • A report with model, protocol, controls and raw data
  • Results per replicate, with mean and spread declared
  • An outcome for each mechanism tested, read together rather than one at a time
  • A comparison between the insult condition and the protected one
  • A readable comparison between the conditions tested, usable in a technical dossier or in a conversation with a downstream customer

Who it is for, and where to start

How we can bring you value

You develop an ingredientand you want evidence your customers can useIngredient validation and valorisation
You develop a finished productand you want to know what stays active in the formulationSupplement valorisation and formulation development

Tell us about your project

Write to us here: the division team will get back to you.